Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation

OBJECTIVE: To evaluate the clinical outcomes following first-line treatment with sorafenib in patients with primary hepatocellular carcinoma (HCC). METHODS: This retrospective cohort study enrolled patients with primary HCC that had been treated with sorafenib. Their data were collected from the hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Dung Thi, Nguyen, Duong Hoang, Nguyen, Van Thi Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291016/
https://www.ncbi.nlm.nih.gov/pubmed/37314298
http://dx.doi.org/10.1177/03000605231179928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291016/
https://www.ncbi.nlm.nih.gov/pubmed/37314298
http://dx.doi.org/10.1177/03000605231179928

Ejemplares similares